We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A decade of promises in personalised cancer medicine: is the honeymoon over?
- Authors
Ward, Robyn L.
- Abstract
The article focuses on the personalised cancer medicine. Topics include a 2012 report from the Institute of Medicine of the U.S. National Academy of Sciences which included a review of omics-based tests' clinical trials at Duke University, the introduction of tyrosine kinase inhibitor imatinib for chronic myleloid leakeamia in 1990s, and the development of anti-epidermal growth factor receptor (EGFR) antibodies.
- Subjects
INDIVIDUALIZED medicine; CANCER treatment; NATIONAL Academy of Medicine (U.S.); DUKE University; IMATINIB; CHRONIC myeloid leukemia; EPIDERMAL growth factor receptors; IMMUNOGLOBULINS
- Publication
Medical Journal of Australia, 2014, Vol 200, Issue 3, p132
- ISSN
0025-729X
- Publication type
Article
- DOI
10.5694/mja14.00018